Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001753926-25-000802·3i, LP
Schedule 13G ownership disclosure
BriaCell Therapeutics Corp.
Common Shares, no par value · CUSIP: 107930208
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 3i, LP
Shares: 190,006.00 · Class: 4.9%
- 3i Management LLC
Shares: 190,006.00 · Class: 4.9%
- Maier Joshua Tarlow
Shares: 190,006.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-25-000802
- Form type
- SCHEDULE 13G/A
- Filer
- 3i, LP
- CIK
- CIK 1841619
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership